Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/1998
04/01/1998EP0831866A1 Pineal gland specific gene-1
04/01/1998EP0831860A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
04/01/1998EP0831852A1 Nucleosides with anti-hepatitis b virus activity
04/01/1998EP0831848A1 Method of treatment for lung diseases using antisense oligonucleotides
04/01/1998EP0831846A1 Capped synthetic rna, analogs, and aptamers
04/01/1998EP0831819A1 Method for inhibiting neoplastic disease in mammals
04/01/1998EP0831812A2 Methods and compositions for stimulating neurite growth
04/01/1998EP0831806A1 Multidentate metal complexes and methods of making and using thereof
04/01/1998EP0831793A1 Protein particles for therapeutic and diagnostic use
04/01/1998EP0831792A2 Apparatus and method for delivering a biologically active compound into a biological environment
04/01/1998EP0831791A1 Delivery of drugs to the lower gi tract
04/01/1998EP0831787A2 Composition for sustained release of human growth hormone
04/01/1998EP0831786A2 Device for releasing aggregation-stabilized, biologically active agent
04/01/1998EP0831782A1 Methods and system for processing dispersible fine powders
04/01/1998EP0831773A1 Peptide/protein suspended formulations
04/01/1998EP0831769A2 Novel uses for thyroid hormones or thyroid hormone-like compounds
04/01/1998EP0831752A1 A device for delivering a preselected molecule into the system circulation
04/01/1998EP0771555A4 Agent for external application with nutrient and protective properties
04/01/1998EP0637318B1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin
04/01/1998EP0625987B1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
04/01/1998EP0573510B1 Anti-growth factor antibodies in the treatment of vascular stenosis
04/01/1998CN1177965A 角质形成细胞生长因子-2 Keratinocyte growth factor-2
04/01/1998CN1177928A Generation of human insulin
04/01/1998CN1177927A Extracts of shark cartilage, process of production and uses thereof
04/01/1998CN1177909A Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
04/01/1998CN1177500A Film for preventing and treating hyperplastic scar and preparation method thereof
03/1998
03/31/1998US5734082 Hydroxyethyl aminimides
03/31/1998US5734081 Arylthio compounds
03/31/1998US5734049 Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
03/31/1998US5734039 Antisense oligonucleotides targeting cooperating oncogenes
03/31/1998US5734038 Purified polynucleotide sequence which codes for a diazepam binding inhibitor protein(or polypeptide) or an acyl-coenzyme a binding protein(or polypeptide)
03/31/1998US5734037 DNA encoding the human cytokine, interleukin-9
03/31/1998US5734034 Nucleic acid ligand inhibitors of human neutrophil elastase
03/31/1998US5734033 Antisense oligonucleotides inhibiting human bcl-2 gene expression
03/31/1998US5734026 Process for manufacturing crystals of growth hormone and crystals thereby obtained
03/31/1998US5734024 Method for determining the biological activity of recombinant human growth hormone
03/31/1998US5734023 Contacting isolated major histocompatibility complex chain component with an autoantigenic peptide such that the peptide is coupled to the antigen binding site to form a complex
03/31/1998US5734022 Antibodies to a novel mammalian protein associated with uncontrolled cell division
03/31/1998US5734018 Biosynthesis detection, analyzing method to obtain peptide sequences
03/31/1998US5734016 Genetic engineering
03/31/1998US5734015 Antibiotics
03/31/1998US5734014 Polypeptide
03/31/1998US5734013 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same
03/31/1998US5734012 Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity
03/31/1998US5733933 Methods and materials for the diagnosis and treatment of conditions such as stroke
03/31/1998US5733928 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
03/31/1998US5733885 Heat treatment of blood for safety
03/31/1998US5733884 Enteral formulation designed for optimized wound healing
03/31/1998US5733881 Analgesics, immunosuppressants
03/31/1998US5733880 Anthracene derivatives for use as anticancer agents
03/31/1998US5733879 Peptides and proteins, process for their preparation and their use as cholesterol acceptors
03/31/1998US5733878 Morphogen-induced periodontal tissue regeneration
03/31/1998US5733877 Pharmaceutical composition containing biologically active peptide or protein
03/31/1998US5733876 Method of inhibiting angiogenesis
03/31/1998US5733875 Epilepsy
03/31/1998US5733874 Stable dry powders
03/31/1998US5733873 Polyoxamers or polyoxyethylene sorbitan fatty acid esters with sodium chloride, calcium chloride, histidine or sugars
03/31/1998US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
03/31/1998US5733871 Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration
03/31/1998US5733870 Ointment for treatment of epithelial lesions
03/31/1998US5733869 Systemically administering stroma-free hemoglobin to a patient experiencing ventricular fibrillation during cardiac pulmonary resuscitation, and defibrillation to effect return of spontaneous cirulation in the patient
03/31/1998US5733790 CRF binding protein antibodies and assays using same
03/31/1998US5733781 Dna and human immunodefficiency virus inhibitors
03/31/1998US5733763 Containing cellulose fibers; stability; flexibility; sustained release
03/31/1998US5733761 Gene therapy
03/31/1998US5733760 Salmonella vectors encoding truncated pag fusion protein, method of making, and uses thereof
03/31/1998US5733748 Isolated polynucleotide; cancer diagnosis
03/31/1998US5733742 Polyclonal immunoglobulin fab fragments
03/31/1998US5733740 Taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
03/31/1998US5733730 Telomere repeat binding factor and diagnostic and therapeutic use thereof
03/31/1998US5733569 Drugs for nasal administering
03/31/1998US5733562 Injectable medical device and method of use
03/31/1998US5733550 Method for enhancing the association of exogenous peptides with class I MHC molecules on the surface of antigen presenting cells with β-microglobulin
03/31/1998US5733548 Stimulating t-cell response
03/31/1998US5733547 Treatment of autoimmune arthritis by oral administration of type I or type III collagen
03/31/1998US5733546 Immunochemical detection of in vivo advanced glycosylation endproducts
03/31/1998US5733543 Genetic engineering; delaying acquired immune deficiency syndrome (aids) onset
03/31/1998US5733540 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
03/31/1998US5733524 Screening for neuroprotective agents by administering them with infarct-producing amine compounds, then comparing responses in treated and untreated animals
03/31/1998US5733446 Centrifuge with annular filter
03/31/1998CA2134889C Calcium channel blocking polypeptides from filistata hibernalis
03/31/1998CA2040441C Fusion proteins
03/31/1998CA1339793C Cyclic analogs of atrial natriuretic peptides
03/31/1998CA1339791C Human nerve growth factor
03/26/1998WO1998012347A1 Rh blood group antigen compositions and methods of use
03/26/1998WO1998012334A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
03/26/1998WO1998012331A1 Novel polypeptide originating in hemophilus paragallinarum and process for producing the same
03/26/1998WO1998012330A1 Mammalian cytokine, related reagents
03/26/1998WO1998012329A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998WO1998012328A2 Human bad polypeptides, encoding nucleic acids and methods of use
03/26/1998WO1998012327A2 Compositions and methods comprising bard1 and other brca1 binding proteins
03/26/1998WO1998012326A1 Hedgehog interacting proteins and uses related thereto
03/26/1998WO1998012325A1 Human gtp binding protein gamma-3
03/26/1998WO1998012324A1 Monocyte chemotactic protein 5 (mcp-5) molecules and uses therefor
03/26/1998WO1998012323A1 Nucleic acid encoding congenital heart disease protein and products related thereto
03/26/1998WO1998012322A1 Bone morphogenetic protein-16 (bmp-16) compositions
03/26/1998WO1998012320A1 Nucleic acid construct coding for a protein complex from a stat protein and a nuclear receptor and its use
03/26/1998WO1998012319A1 Broad spectrum therapeutic peptide
03/26/1998WO1998012318A1 Thrombin inhibitor
03/26/1998WO1998012317A1 Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agents